Data as of Jan 23
| +0.20 / +9.48%|
The 7 analysts offering 12-month price forecasts for Solazyme Inc have a median target of 5.00, with a high estimate of 7.50 and a low estimate of 2.00. The median estimate represents a +116.45% increase from the last price of 2.31.
The current consensus among 7 polled investment analysts is to Hold stock in Solazyme Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.